Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Axogen IncAXGN | $33.32 | Strong Buy | $37.00 | +11.04% | a day ago | |
Analyst RankingTop 18% #931 out of 5134 analysts Average Return+16.65% Win Rate48%14 out of 29 Risk vs RewardPoor Good Analyst ColorCanaccord Genuity's Caitlin Cronin raised their price target on Axogen (NASDAQ: AXGN) by 37% from $27 to $37 on 2025/12/05. The analyst maintained their Strong Buy rating on the stock. Axogen announced that the FDA approved the BLA (Biologics License Application) for AVANCE®, transforming the drug from a tissue-regulated to a fully licensed biologic, Cronin told readers. The approval extends to both children and adults who have peripheral nerve discontinuities in the sensory, mixed-function, or motor domains, the analyst detailed. Cronin said the approval will significantly boost commercial covered lives, as well as adoption among society and surgeons. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | 2 days ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to ? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.